Cargando…
Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645270/ http://dx.doi.org/10.1186/2051-1426-3-S2-P162 |
| _version_ | 1782400797078716416 |
|---|---|
| author | Crittenden, Marka Bahjat, Keith S Li, Rui Gore, Pankaj Fountain, Chris Hanson, Bill Skoble, Justin Lauer, Peter Murphy, Aimee L Dubensky, Thomas Brockstedt, Dirk G Urba, Walter |
| author_facet | Crittenden, Marka Bahjat, Keith S Li, Rui Gore, Pankaj Fountain, Chris Hanson, Bill Skoble, Justin Lauer, Peter Murphy, Aimee L Dubensky, Thomas Brockstedt, Dirk G Urba, Walter |
| author_sort | Crittenden, Marka |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645270 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46452702015-11-20 Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas Crittenden, Marka Bahjat, Keith S Li, Rui Gore, Pankaj Fountain, Chris Hanson, Bill Skoble, Justin Lauer, Peter Murphy, Aimee L Dubensky, Thomas Brockstedt, Dirk G Urba, Walter J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645270/ http://dx.doi.org/10.1186/2051-1426-3-S2-P162 Text en Copyright © 2015 Crittenden et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Crittenden, Marka Bahjat, Keith S Li, Rui Gore, Pankaj Fountain, Chris Hanson, Bill Skoble, Justin Lauer, Peter Murphy, Aimee L Dubensky, Thomas Brockstedt, Dirk G Urba, Walter Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas |
| title | Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas |
| title_full | Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas |
| title_fullStr | Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas |
| title_full_unstemmed | Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas |
| title_short | Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas |
| title_sort | phase i study of safety and immunogenicity of adu-623, a live-attenuated listeria monocytogenes vaccine (δacta/δinlb) expressing egfrviii and ny-eso-1, in patients with who grade iii/iv astrocytomas |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645270/ http://dx.doi.org/10.1186/2051-1426-3-S2-P162 |
| work_keys_str_mv | AT crittendenmarka phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas AT bahjatkeiths phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas AT lirui phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas AT gorepankaj phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas AT fountainchris phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas AT hansonbill phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas AT skoblejustin phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas AT lauerpeter phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas AT murphyaimeel phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas AT dubenskythomas phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas AT brockstedtdirkg phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas AT urbawalter phaseistudyofsafetyandimmunogenicityofadu623aliveattenuatedlisteriamonocytogenesvaccinedactadinlbexpressingegfrviiiandnyeso1inpatientswithwhogradeiiiivastrocytomas |